Is That a Medical Device?
It’s a question on many IWLA members’ minds: Do I handle products considered “medical devices?” This is an even more important question now, as U.S. Rep. Fred Upton (R-MI), chairman […]
It’s a question on many IWLA members’ minds: Do I handle products considered “medical devices?” This is an even more important question now, as U.S. Rep. Fred Upton (R-MI), chairman […]
The U.S. Food and Drug Administration has unveiled yet another guidance document outlining the information that needs to be reported to the FDA. This document covers timing, formatting and a […]
The U.S. Food and Drug Administration issued guidance for the Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, and Prescription Drugs. The document establishes initial […]
IWLA has been working with others in the Device Distribution Group to develop uniform licensing of 3PLs in the medical device supply chain. This legislation is designed to mirror the […]
The U.S. Food and Drug Administration recently released recommendations in question-and-answer format for the purposes of clarifying the Drug Quality Security Act. However, several contradictions in the state and federal […]
In a letter sent Sept. 9, U.S. Representative Fred Upton (R-Mich.), chairman of the House Committee on Energy and Commerce and author of the U.S. Food and Drug Administration (FDA) […]
IWLA has been closely engaging the California Board of Pharmacy after issuance of AB 2605, a statewide pharmaceutical licensing requirement on third-party logistics providers. IWLA members fully support licensing standards […]
The California Assembly Committee passed AB 2605 on April 29. The bill imposes a statewide licensing requirement on third-party logistics providers in the pharmaceutical supply chain. The legislation is inconsistent with […]
The International Warehouse Logistics Association (IWLA) is following implementation of the Drug Quality and Security Act (DQSA) closely. The DQSA was signed into law on Nov. 27, 2013. According to […]
Under the Drug Quality and Security Act, 3PLs will required to comply with national licensing standards (and/or potentially state licensing standards) including: Establish a process for third-party accreditation; provide for periodic inspection; prohibit a facility from […]